Introduction:
In a significant judgment reinforcing the principle that criminal liability under the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) cannot be presumed in the absence of conscious involvement or criminal intent, the Punjab and Haryana High Court set aside charges framed against a licensed medical dealer who had been implicated in an NDPS case primarily on the basis of a co-accused’s disclosure statement. The decision was rendered by Justice H.S. Grewal in Anil Kumar Kaushik v. State of Punjab.
The case arose from an FIR registered at Police Station City Kotkapura, District Faridkot, Punjab. The prosecution case initially stemmed from the interception of a canter vehicle by the police during which a large quantity of Lomotil tablets, amounting to 31,020 tablets, was allegedly recovered from two individuals, namely Jaspal Singh alias Rinku and Harjinder Singh alias Kala. The recovered tablets fell within the category of intoxicating pharmaceutical preparations, attracting the provisions of the NDPS Act.
During the course of investigation, one of the arrested accused allegedly disclosed that the recovered tablets had been purchased from the petitioner, Anil Kumar Kaushik, who operated a licensed medical store in Delhi. Based solely on this disclosure statement, the investigating agency nominated the petitioner as an accused under Section 29 of the NDPS Act, which deals with criminal conspiracy and abetment.
Following his nomination, the police conducted a search of the petitioner’s premises. During the search, various pharmaceutical products including Lomotil tablets, Alprazolam-based medicines, and Tramadol-containing drugs were recovered from a store room situated behind the petitioner’s medical shop. The prosecution treated this recovery as a circumstance indicating illegal involvement in the trafficking of narcotic and psychotropic substances.
The petitioner consistently maintained that he was a licensed dealer authorized to stock and sell the medicines recovered during the search. He argued that the medicines had been supplied during the ordinary course of business and that he had no knowledge that the documents produced by the purchaser were forged. He further relied upon a departmental inquiry conducted by a Deputy Superintendent of Police (DSP), which verified the authenticity of his licence and found no evidence suggesting his involvement in illegal drug trafficking.
Despite these developments, the Special Court at Faridkot dismissed his application for discharge and framed charges against him under Section 22(c) read with Section 29 of the NDPS Act. Aggrieved by this decision, the petitioner approached the Punjab and Haryana High Court through a revision petition under Section 401 of the Code of Criminal Procedure.
The case raised important legal questions concerning the evidentiary value of disclosure statements, the extent of criminal liability of licensed pharmaceutical dealers under the NDPS Act, and the degree of material required to frame charges in cases involving regulated medicinal substances.
Arguments of the Parties:
The petitioner challenged the order of the Special Court on multiple grounds, contending that the prosecution had failed to produce any legally admissible material linking him to unlawful trafficking of narcotic or psychotropic substances. According to the petitioner, his implication in the case rested entirely upon the disclosure statement allegedly made by a co-accused during police investigation.
It was argued that under settled principles of criminal jurisprudence, a disclosure statement made by a co-accused has extremely limited evidentiary value and cannot, by itself, become the sole basis for prosecution unless supported by independent corroborative evidence. The petitioner submitted that apart from the disclosure statement, the investigating agency had failed to uncover any material demonstrating his involvement in an illegal supply chain or narcotics network.
The petitioner further emphasized that he was a duly licensed medical dealer operating under the regulatory framework governing pharmaceutical products. The medicines recovered from his premises were legally stockable and saleable items under the licence granted to him by the competent authorities. Therefore, the mere possession or storage of such medicines could not constitute an offence under the NDPS Act.
A crucial aspect of the petitioner’s defence was that the medicines had been supplied in the ordinary course of business after the purchaser had produced documents and licences that appeared genuine at the relevant time. The petitioner maintained that he had acted in good faith and had no knowledge whatsoever that the documents later turned out to be forged.
The petitioner also relied heavily upon the findings of a departmental inquiry conducted by a DSP-level officer. The inquiry reportedly verified the validity of the petitioner’s licence and concluded that there was no evidence indicating his deliberate involvement in illegal trafficking. Pursuant to this inquiry, a supplementary report under Section 173(8) Cr.P.C. was filed in his favour. However, according to the petitioner, the trial court failed to adequately consider this significant exculpatory material while framing charges.
Another argument raised by the petitioner related to the recovery effected during the search of his premises. He submitted that the medicines were recovered from a store room situated behind the shop, which formed part of his business operations. Merely because the recovery was made from a location slightly different from the exact address specified in the licence could not justify an inference that the medicines were illegally stored or concealed.
The State of Punjab opposed the revision petition and supported the order passed by the Special Court. The prosecution argued that the quantity of intoxicating tablets recovered during the investigation was substantial and constituted a commercial quantity under the NDPS Act. The seriousness of the offence, according to the State, justified continuation of the prosecution.
The State also relied upon the disclosure statement of the co-accused, who had allegedly identified the petitioner as the supplier of the recovered tablets. According to the prosecution, the disclosure statement, coupled with the subsequent recovery of medicines from the petitioner’s premises, constituted sufficient material to proceed against him.
The prosecution further contended that the recovery of controlled pharmaceutical substances from a store room located behind the licensed premises raised serious suspicion regarding the manner in which the medicines were being stored and supplied. It was argued that such circumstances warranted a full-fledged trial rather than discharge at the preliminary stage.
The State maintained that issues concerning the petitioner’s knowledge, intention, and degree of involvement could be determined only after appreciation of evidence during trial. Therefore, according to the prosecution, the Special Court was justified in framing charges and directing the petitioner to face trial.
The dispute before the High Court thus centred on whether the available material disclosed a prima facie case of criminal involvement under the NDPS Act or whether the prosecution was merely based on suspicion unsupported by legally sustainable evidence.
Court’s Judgment:
After examining the record and the circumstances of the case, the Punjab and Haryana High Court found substantial merit in the petitioner’s challenge and concluded that the order framing charges could not be sustained.
Justice H.S. Grewal began by examining the basis on which the petitioner had been implicated in the case. The Court observed that the petitioner had initially been nominated as an accused solely on the basis of a disclosure statement made by a co-accused during police investigation. Significantly, the Court noted that the prosecution had failed to produce independent incriminating material connecting the petitioner with any illegal trafficking activity.
The Court reiterated the settled legal position that a disclosure statement made by a co-accused cannot automatically establish criminal liability unless supported by credible corroborative evidence. Criminal prosecution, particularly under a stringent statute such as the NDPS Act, cannot proceed merely on suspicion or assumptions.
A major factor influencing the Court’s decision was the undisputed fact that the petitioner possessed a valid licence authorizing him to deal in pharmaceutical products. The Court noted that the medicines recovered from his premises were medicines that he was legally entitled to stock and sell under the authority of his licence.
The High Court attached considerable significance to the DSP-level departmental inquiry conducted during the investigation. The inquiry had verified the authenticity of the petitioner’s licence and found him innocent of any deliberate wrongdoing. The Court observed that the trial court had failed to properly appreciate the importance of this material while framing charges.
The Court also considered the allegation that medicines were recovered from a store room situated behind the licensed shop rather than from the precise location mentioned in the licence. Rejecting the prosecution’s attempt to draw adverse inferences from this circumstance, Justice Grewal held that such a fact, standing alone, could not establish criminal intent or illegal activity.
The Court made a significant observation that merely because medicines were recovered from a storage area adjacent to or behind the licensed premises does not automatically convert a lawful business activity into a criminal enterprise. Unless there is evidence demonstrating deliberate concealment, unlawful diversion, or unauthorized dealing, the location of recovery by itself cannot establish guilt.
The judgment emphasized that the NDPS Act requires proof of conscious possession, knowledge, intent, or active participation in unlawful activities. Criminal liability cannot be imposed merely because a licensed dealer supplied medicines which were subsequently misused by purchasers.
The Court found that there was no material demonstrating that the petitioner had knowledge that the medicines would be used for illegal purposes. Equally absent was any evidence showing intentional participation in a criminal conspiracy, conscious facilitation of unlawful trafficking, or deliberate diversion of pharmaceutical products into illegal channels.
Justice Grewal observed that the prosecution had failed to establish the essential ingredients necessary to attract Sections 22(c) and 29 of the NDPS Act. The record did not disclose any circumstance suggesting that the petitioner knowingly aided, abetted, or conspired in the commission of an NDPS offence.
The Court also took note of the petitioner’s explanation that the purchaser had produced documents appearing to be genuine at the time of transaction and that the forged nature of those documents came to light only subsequently. In the absence of evidence indicating prior knowledge of forgery, the Court held that criminal liability could not be fastened upon the petitioner merely because the purchaser later turned out to be involved in unlawful activities.
The judgment serves as an important reminder that the rigorous provisions of the NDPS Act, while designed to combat drug trafficking, cannot be applied mechanically against individuals engaged in lawful and regulated business activities. The Court stressed that the statute does not eliminate the fundamental requirement of proving criminal intent and conscious involvement.
Concluding that the prosecution case lacked the necessary factual and legal foundation, the High Court held that the order passed by the Special Court framing charges against the petitioner was unsustainable in law. Accordingly, the revision petition was allowed, the impugned order was set aside insofar as it related to the petitioner, and he was discharged from the case.
However, the Court clarified that the criminal proceedings would continue against the remaining accused in accordance with law. The judgment thus strikes a careful balance between the objectives of the NDPS Act and the fundamental principles of criminal justice, reaffirming that legitimate businesspersons cannot be prosecuted merely on the basis of suspicion, disclosure statements, or circumstances that do not establish conscious criminal involvement.